Hepatitis C infection in liver transplantation (Q34725183)

4 August 2017

1 reference

title

Hepatitis C infection in liver transplantation (English)

1 reference

4 August 2017

liver transplantation

1 reference

1 reference

Charlton M

1

1 reference

PubMed ID

12102252

4 August 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

American Journal of Transplantation

4 August 2017

1 reference

4 August 2017

1

1 reference

4 August 2017

3

1 reference

4 August 2017

197-203

1 reference

Long-term outcome of hepatitis C infection after liver transplantation

4 August 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.001003197.X

Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.001003197.X

Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high-titer viremia correlates with advanced stage of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.001003197.X

Chronic non-A, non-B hepatitis: lack of correlation between biochemical and morphological activity, and effects of immunosuppressive therapy on disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.001003197.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.001003197.X

Prophylaxis against HCV recurrence after liver transplantation: effect of interferon and ribavirin combination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.001003197.X

Peginterferon alfa-2a in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.001003197.X

Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.001003197.X

Treatment of recurrent hepatitis C virus infection after liver transplantation with interferon and ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.001003197.X

Liver transplantation in hepatitis C. A Spanish multi-centre experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.001003197.X

7 January 2021

Recurrent and new hepatitis C virus infection after liver transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.001003197.X

7 January 2021

Predictors of patient and graft survival following liver transplantation for hepatitis C.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.001003197.X

7 January 2021

European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.001003197.X

7 January 2021

Hepatitis C genotypes in liver transplant recipients: distribution and 1-year follow-up

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.001003197.X

7 January 2021

Short-term prednisone therapy affects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.001003197.X

7 January 2021

A longitudinal analysis of hepatitis C virus replication following liver transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.001003197.X

7 January 2021

Interferon-alpha therapy for hepatitis C virus infection after liver transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.001003197.X

7 January 2021

The efficacy of prophylactic interferon alfa-2b in preventing recurrent hepatitis C after liver transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.001003197.X

7 January 2021

Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.001003197.X

7 January 2021

Successful rescue of severe recurrent hepatitis C with interferon and ribavirin in a liver transplant patient.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.001003197.X

7 January 2021

A model to predict survival following liver retransplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.001003197.X

7 January 2021

Incidence of hepatitis C in patients receiving different preparations of hepatitis B immunoglobulins after liver transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.001003197.X

7 January 2021

A pilot study of ribavirin therapy for recurrent hepatitis C virus infection after liver transplantation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-6143.2001.001003197.X

7 January 2021

10.1034/J.1600-6143.2001.001003197.X

Identifiers

DOI

1 reference

4 August 2017

1 reference

PubMed ID

12102252